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J. C. JACOBS, A. T. MASI, J. G. SCHALLER, J. F. FRIES, D. McSHANE, and D. YOUNG 
Criteria for the classification of juvenile rheuma- 
toid arthritis were analyzed in a detailed database of 250 
children in order to assess the accuracy of diagnosis and 
validity of onset types and course subtypes, A number of 
concliusions have been derived from this study: 1) All 
definitions of the 1973 criteria for classification of juve- 
nile rheumatoid arthritis should be retained. 2) The 
addition of onset types to the 1976 revision of the criteria 
has been validated. 3) The course of the disease after the 
onset period of 6 months is as important to the outcome 
of a group of children as is the onset type. 4) The current 
classification should be broadened to include the course 
subtypes. 
In 1963, Dr. Marian Ropes, President of the 
American Rheumatism Association (ARA), appointed 
a committee to study classification criteria for juvenile 
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rheumatoid arthritis. A set of criteria, including a long 
list of diagnostic exclusions, was developed on the 
basis of clinical experience, and it was determined that 
the term juvenile rheumatoid arthritis (JRA) should be 
restricted to chronic arthritis developing in children 
younger than age 16, and should be based on demon- 
stration of objective signs of inflammatory joint in- 
volvement. These criteria were subsequently evalu- 
ated both in retrospective and in prospective studies 
(1). Modifications of the original criteria were devel- 
oped in 1976, to place greater emphasis on the 3 onset 
types that had been identified (2). 
The present study, by the Subcommittee on 
Classification Criteria for a Diagnosis of Juvenile 
Rheumatoid Arthritis, a subcommittee of the Diagnos- 
tic and Therapeutic Criteria Committee of the ARA, 
was begun in 1977 to evaluate these onset types. The 
subcommittee used the computerized database that 
had been meticulously compiled over many years by 
Dr. Joseph Levinson and his associates at the Uni- 
versity of Cincinnati. In this report, we review the 
results of this study of onset types and course 
subtypes in children with JRA. Although extensive 
analyses were done, only those results specifically 
addressing classification are presented. 
PATIENTS AND METHODS 
Children diagnosed as having JRA met the classifi- 
cation criteria established in 1976 (2). All children referred to 
the University of Cincinnati between 1958 and 1978, who 
satisfied the entry criteria were enrolled in the study. The 
characteristics of the Cincinnati study group are shown in 
Table 1. The study entry times were not controlled by any 
predetermined design except for the point at which the child 
was referred to the unit for evaluation; the point of exit from 
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Table 1. Characteristics of the Cincinnati database study group* 
Characteristic n 
disease onset with subsequent monarthric, oligoarthric, or 
polyarthric courses. 











Possible or probable JRA 














* JRA = juvenile rheumatoid arthritis: early entry = entry into the 
study during the first 6 months of disease; late entry = entry into the 
study after the first 6 months of disease; possible JRA = history of 
arthritis, but objective arthritis not documented by physician enter- 
ing the child into the study; probable JRA = objective arthritis of 
less than 6 weeks duration. 
the study was subject to the usual biases of referral patterns 
and the mobility of the child’s parents. All data for the study 
were entered prospectively, on standardized forms. Children 
examined at Cincinnati within the first 6 months after disease 
onset were classified as the early-entry group, and children 
entered into the study after this period of time were the 
late-entry group. For the latter group of children, the char- 
acteristics of the onset period were determined from their 
medical fecords. 
The children were reexamined at 6-month intervals 
throughout the study period. Routine laboratory tests re- 
quired according to the clinical status of the child were 
performed at each visit, along with ophthalmologic exami- 
nations. Conventional radiologic films of affected joints were 
obtained at disease onset and then every 2 years thereafter. 
Fluorescent antinuclear antibody (ANA) preparations used 
cryostat sections of human thyroid as substrate (positive 
> 1 : 10). Rheumatoid factors were determined by a slide latex 
test (Hyland, Costa Mesa, CA) and confirmed by the Rose- 
Waaler sensitized sheep cell agglutination test (SCAT; pos- 
itive >1:4). All data were entered into the ARA Medical 
Information System (ARAMIS) at Stanford University and 
were analyzed by standard statistical programs. 
The early-entry versus late-entry groups were exten- 
sively analyzed based upon previously identified segregating 
factors. Numerous comparisons were also made among the 3 
onset types regarding key variables such as SCAT positivity, 
ANA positivity, HLA-B27 positivity, development of 
uveitis, remission before or after 5 years, and development 
of erosions; standard variables of age at disease onset, 
cumulative number of inflamed joints, and number of in- 
flamed joints counted at each visit; and sex. The subsequent 
course of each child was also analyzed according to the 
following: (a) those with systemic onset disease which 
developed into a polyarthric course versus into an oligo- 
arthric or pauciarticular course; (b) those with systemic 
onset disease and a polyarthric course versus those who had 
a polyarthric onset; and (c) those with oligoarthritis at 
RESULTS 
Early-entry versus late-entry group. An exten- 
sive comparison of the early- versus late-entry groups 
for each of the 3 onset types was performed. No 
significant differences were identified between the 
early- and late-entry groups for any onset type. Thus, 
these 2 groups of children were combined for all 
subsequent analyses. 
SCAT, ANA, and HLA-B27 positivity. Figure 1 
shows the number of children in each of the 3 onset 
groups, segregated by results of tests for SCAT, ANA, 
and HLA-B27 type. The small numbers in certain 
groups made statistical analyses impossible for many 
of the associations. For example, there was only 1 
child who had oligoarthritis and had positive results on 
SCAT, ANA, and B27 determinations. 
SCAT ANA HLA-627 Total number Onset type 
Polyarthritts 
\ 1 6 + 7 : s  
Figure 1. Frequencies of positive or negative results on sheep cell 
agglutination test (SCAT), antinuclear antibody test (ANA), and 
typing for HLA-B27, according to disease onset type. 
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Table 2. Characteristics of children with juvenile rheumatoid arthritis, according to disease onset type and disease duration 
Polyarthritis Oligoarthritis Systemic disease 
followup at (years) followup at (years) followup at (years) 
'h 3 5 7 10 '/2 3 5 7 10 L/z 3 5 7 10 
No. of children 
% male 
Age at disease onset 
(years, mean) 
No. ofjoints involved 







Cumulative no. of 
Cervica.1 spine (%) 
joints 
41 51 46 37 23 64 79 65 47 34 26 26 21 18 15 
20 22 28 22 17 37 30 26 28 18 27 27 33 33 47 
8.3 8.5 8.7 8.3 7.2 6.5 6.7 6.8 6.0 5.6 7.3 7.1 5.7 5.0 4.2 
8 10 11 12 10 3 3 4 6 4 6 8 13 6 17 
22 27 31 49 30 6 9 15 19 21 18 19 19 39 40 
29 31 39 54 35 10 9 17 23 26 31 I5 29 28 40 
7 8 22 30 13 2 0 2 4 6 15 15 14 11 40 
2 10 28 35 13 3 5 9 4  9 15 19 24 33 33 
44 31 35 49 30 38 15 32 28 24 23 23 29 28 40 
2 6 11 32 13 2 0 3 9 9 8 12 0 6 13 
12 17 20 28 25 3 6 7 8 9 6 13 16 17 21 
Frequency of clinical characteristics. Tables 2 
and 3 summarize the frequency of clinical and labora- 
tory characteristics of the children with JRA, accord- 
ing to onset type. For convenience, only data at 
followuip times of V2, 3, 5, 7, and 10 years are shown. 
There were too few children evaluated at 15 years for 
that time point to be included. The variation in the 
number of children at each interval reflects the fact 
that additional children were being entered into the 
study as it progressed, and other children were lost to 
followup. Based on this compilation of cases, conclu- 
sions from this criteria study reflect predominantly 
cross-sectional analysis and not sequential followup of 
single c,ases. 
IPolyarthritis. SCAT seropositivity in relation to 
clinical features of the disease was assessed for chil- 
dren with polyarthritis versus those with oligoarthritis; 
results of these comparisons are shown in Table 4. 
Sixteen children with polyarthritis and 9 with oligoar- 
thritis were SCAT-positive. In each group, the age at 
disease onset was somewhat older in the seropositive 
children than in a corresponding group of seronegative 
patients, and there were more females, a higher per- 
centage of ANA seropositivity, predominant involve- 
ment of the small joints of the hands, and a higher 
frequency of erosions that occurred during the disease 
course. 
Cluster analysis identified the number of joints 
involved (5 or more) as the most important variable 
associated with outcome (course at 5 years or more) in 
children with polyarthritis. SCAT positivity was the 
next most important variable, and beyond that, a 
weaker identification of female sex as an important 
variable was made. 
Table 3. Characteristics of children with juvenile rheumatoid arthritis, according to disease onset type and disease duration 
Pol yarthritis Oligoarthritis Systemic disease 
followup at  (years) followup at (years) followup at (years) 
Y2 3 5 7 10 Y2 3 5 7 10 Y2 3 5 7 10 
Articular erosions (%) 10 28 69 81 63 6 13 15 18 17 0 25 29 80 60 
Functional class 1.7 1.7 1.8 1.8 1.6 1.5 1.4 1.4 1.3 1.6 1.7 1.4 1.6 1.4 1.9 
Intermittent fever 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  
Rheumatoid rash (%) 0 0 0 0 0 0 0 0 0 0 1 9 0 1 0 1 1  7 
Hepatomegaly (%) 6 6 2 3 1 3 5 3 0 0 3 4 8 1 4 1 1  7 
Rheumatoid factors (%) 4 8 1 4 1 1  9 3 1 0 4 7 0 0 0 0 0  
Lymphadenopathy (%) 25 41 49 54 46 23 49 55 57 47 54 62 48 44 40 
Splenomegaly (%) 3 2 0 3 0 5  1 0 0 0 0 0 1 0 6 1 3  
Rheumatoid nodules (%) 3 8 15 24 21 0 5 8 9 9 4 8 1 0 1 1 1 7  
Antinuclear antibodies (%) 53 42 38 48 42 41 39 30 40 29 5 0 0 0 0 
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Table 4. 
SCAT-positive* 
Selected clinical parameters for children with polyarthritis and oligoarthritis who were 
Polyarthritis Oligoarthritis 
R F +  RF- P RF+ RF- P 
- 
No. of children 16 62 - 9 112 - 
Age at disease onset (years, 9.6 8.1 NC 8.6 6.1 NC 
No. males (%) 2 (13) 17 (27) :NC 1 (11)  32 (29) NC 
ANA+, n/total (%) 15/16 (94) 23/57 (40) <0.01 6/9 (67) 601109 ( 5 5 )  NC 
Hand joints involved, n/total 16/16 (100) 52/62 (84) <0.05 9/9 (100) 491112 (44) NC 
Erosions, n/total (%) 12/15 (80) 28/58 (48) 10.05 8/9 (89) 191107 (18) <O.OOl 
* SCAT = sheep cell agglutination test; R F  = rheumatoid factor; NC = statistic not computed because 
of too few values; ANA = antinuclear antibodies. 
mean) 
(%) 
Oligoarthritis or pauciarticular onset. Children 
with oligoarthritis were defined as those developing 
arthritis in 4 or fewer joints. Oligoarthritis was pre- 
dominantly a disease of the lower extremities. Joints 
of the lower extremities were involved in 90% of the 
children at disease onset. Even after 10 years of 
followup, only 26% of these children had upper ex- 
tremity involvement. 
Children with oligoarthritis might have an 
oligoarthric disease course, develop polyarthritis, or 
continue with a single joint involved (monarthritis). 
Except for the number of joints involved, the only 
important variable that correlated with disease course 
was functional class, which tended to be poorer in 
those children with a polyarthric course. Numbers of 
erosions were similar in all oligoarthric groups at the 
longer followup intervals. 
Two subsets of JRA patients were identified 
under this onset type. The first included young girls 
who were ANA-positive and either had or developed 
chronic uveitis (iridocyclitis) (17 of 121, 14%). The 
characteristics of this group were striking throughout 
the course of the disease. Cluster analysis identified 
the lack of involvement of the wrists, female sex, 
ANA positivity, and involvement of the joints of the 
lower extremities as important characteristics in de- 
fining this subset. This group showed little change in 
type of arthritis during the course of the disease. A 
second group of children was identified; they were 
SCAT-positive and had a disease course characteristic 
of polyarthritis (9 of 121, 5%). Cluster analysis con- 
firmed that wrist involvement was frequent, erosions 
tended to develop early, and iridocyclitis occurred 
infrequently. 
Additional observation is required to classify 
the other children in this onset type; however, a 
group of SCAT-negative children was identified (12 of 
121, 9%), and these children tended to be boys who 
were older at disease onset and were B27-positive. 
Outcome analysis of these children at a mean disease 
duration of 7 years indicated that there was no clinical 
or radiologic identification of disease in their hips, 
shoulders, or sacroiliac joints. In many of the remain- 
ing children with oligoarthric onset, the disease re- 
mained persistently pauciarticular. 
Systemic onset. Children with systemic onset 
JRA were defined as those who displayed a daily or 
twice-daily intermittent fever for at least 2 weeks. By 
2-5 years after disease onset, systemic manifestations 
such as pericarditis had subsided, and the course of 
the disease thereafter was predominantly related to the 
number of joints involved: either polyarthritis or 
oligoarthritis. Erosions developed in 45% of these 
children, and in 25% of the group, functional class 
deteriorated during the course of the disease. Devel- 
opment of a typical JRA rash was limited to children in 
this group. 
Two subsets of JRA were identified in children 
with systemic disease. At disease onset, 25 of 28 
children (early-entry group) had 4 or fewer joints 
involved (oligoarthritis). This onset subtype was asso- 
ciated with a favorable outcome. Three of 28 children 
had involvement of 5 or more joints. These latter 
children had a course typical of polyarthritis, with a 
poorer outcome. It is important to note that results of 
serologic studies (SCAT and ANA) were almost in- 
variably negative in children with systemic onset dis- 
ease, irrespective of the number of joints involved at 
onset or during the course of the disease. 
Children with systemic onset disease who had 
oligoarthritis at onset were compared with those chil- 
dren who presented with systemic disease and polyar- 
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Table 5. Course of juvenile rheumatoid arthritis in children with 
systemic onset with oligoarthritis versus those with oligoarthritis 
without systemic onset* 
Oligoarthritis 
Systemic without 
onset with systemic 
oligoarthritis onset P 
No. aiales/total 17/30 (57) 18/43 (42) NC 
Age ait disease onset 4.8 7.6 NC 
Duration (years, mean) 2.6 I .6 NC 
Erosions (%) 38 10 C0.01 
Knee joint involvement 17 47 <0.01 
Hip involvement (%) 25 3 <0.01 




* Children with oligoarthritis without systemic onset were those 
who were sheep cell agglutination test-negative, antinuclear anti- 
body-negative, HLA-Bz7-negative. NC = statistic not computed 
because of too few values. 
thritis. The average age at onset (5.7 versus 7.0 years) 
and l.he frequency of boys (45% versus 57%) were 
greater in the latter group (statistical analysis not done 
because of too few values). At the last followup, the 
presence of active synovitis in all of the children with 
oligoarthritis was significantly greater than that in the 
childiren with systemic onset disease and polyarthritis 
(11 of 11 versus 29 of 40, respectively, P < 0.001). 
Table 5 displays the characteristics of the dis- 
ease in 30 children with systemic onset who had 
oligoarthritis during their disease course, compared 
with 43 children with SCAT-, ANA-, and B27-negative 
oligoarthritis who did not have a systemic onset. 
Variables that reached statistical significance included 
the gireater frequency of erosions, involvement of the 
hips, and radiographic identification of ankylosis of the 
cervical spine in the former group, and predominant 
involvement of the knees in the latter group. 
Chronic uveitis. The development of chronic 
uveitis was analyzed in children with polyarthritis and 
in those with oligoarthritis in order to confirm the 
previously reported characteristics of these defined 
subsets. However, only 4 children with polyarthritis 
developed chronic uveitis during the course of their 
disease. In general, children who developed uveitis, 
irresplective of onset type, tended to be younger at 
disease onset, female, and ANA-positive. 
HLA-B27. Table 6 shows the results of selected 
variables in 12 children who were B27-positive and 
presented with oligoarthritis. These children tended to 
be older at disease onset than the corresponding group 
Table 6. 
oligoarthritis* 
Selected clinical parameters in HLA-B27-t children with 
B27+ B27- P 
No. of children 




Wrist involvement (%) 
Erosive arthritis (%) 
SI joint involvement (%) 
Chronic uveitis (%) 
12 I09 - 
75 22 c0.01 
27 37 NC 
33 20 <0.01 
18 10 <0.001 
0 1 NC 
0 2 NC 
7.5 6.3 <0.001 
0 19 <0.001 
~ ~ ~ ~ ~~ 
* SCAT = sheep cell agglutination test; ANA = antinuclear anti- 
bodies; NC = not computed because of too few values. SI = 
sacroiliac. 
and had a lower frequency of SCAT positivity, more 
frequent involvement of the wrists, and early develop- 
ment of erosions. The 9 boys who were B27-positive, 
and who might have been suspected of developing 
ankylosing spondylitis in the future, were followed 
clinically and radiologically for an average duration of 
7 years. At the end of this period of observation, none 
of these children had features of juvenile ankylosing 
spondylitis. 
Outcome. Table 7 includes data on the 5-year 
outcome for the early-entry group of 138 children. 
These results were not significantly different from 
those of the late-entry group of children. During the 
course of disease, defined as the M-year to 4-year 
Table 7. Disease course and outcome of the early-entry group (138 
children) at 5 years, according to onset type* 
Polyarthric Oligoarthric Systemic 
onset onset onset 
(n = 48) (n = 71) (n = 19) 
Disease course? 
Remission 15/48 1217 I 9/19 
Polyarthric 26/48 1817 I 5/19 
Oligoarthric 7148 41171 5119 
Disease outcome$ 
Remission course 
Continued remission 8/15 7/12 919 
Developed oligoarthritis 0115 3/12 019 
Developed polyarthritis 7/15 2112 019 
Disease remission 4/26 3/18 315 
Became oligoarthric 3126 5/18 115 
Continued polyarthric 19/26 10118 115 
Disease remission 017 14/4 1 215 
Continued oligoarthric 517 2314 1 215 
Developed polyarthritis 217 414 I I I5 
* Those children who entered the study during the first 6 months of 
disease. 
t From 6 months to 4 years. 
$ From year 4 to year 5. 
Polyarthric course 
Oligoarthric course 
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interval, 15 children who had a polyarthric onset, 12 
with an oligoarthric onset, and 9 with a systemic onset 
entered disease remission. Of these 3 groups, 8 of 15 
children with polyarthritic onset remained in remis- 
sion; 7 of 12 with oligoarthric onset and 9 of 9 with 
systemic onset remained in remission. However, 7 of 
the 15 children with polyarthric onset experienced a 
subsequent exacerbation, as did 2 of the 12 with a 
pauciarticular onset. 
Twenty-six children with an onset character- 
ized as polyarthritis experienced a polyarthric course. 
Four of these entered remission, 3 developed oligoar- 
thritis sometime during the course of the disease, and 
19 continued with polyarthritis. Eighteen children with 
pauciarticular onset were in this course subtype. 
Three of 18 entered remission, 5 continued with an 
oligoarthric course, and 10 developed polyarthritis. 
Five children with systemic onset experienced a 
polyarthric course. Three entered remission, 1 devel- 
oped oligoarthritis, and 1 continued with polyarthritis. 
Seven of the 15 children with polyarthritis had an 
oligoarthric course; 5 of these children remained 
oligoarthric, whereas 2 became polyarthric during the 
course of the disease. Fourteen of 41 children with 
oligoarthritic onset who had an oligoarthric course 
entered remission, 23 continued with oligoarthritis, 
and 4 developed polyarthritis. Two of 5 children with 
systemic onset and an oligoarthric course entered 
remission, 2 continued with oligoarthritis, and 1 devel- 
oped polyarthritis. 
DISCUSSION 
There exist no uniformly accepted criteria for 
the various forms of idiopathic inflammatory periph- 
eral arthritis in children. During the past 30 to 40 
years, several authors have proposed sets of criteria 
for these diseases. Bywaters in 1968 (3), Laaksonen in 
1970 (4), Ansell in 1978 (3, and Kvien et a1 in 1982 (6) 
have reviewed the characteristics of these criteria. In 
addition to the criteria proposed by this subcommittee 
of the ARA, criteria by the English ( 3 3 )  and the 
European League Against Rheumatism (EULAR)- 
World Health Organization (WHO) Workshop were 
compiled in Oslo in 1977 (7). 
The term juvenile rheumatoid arthritis, adopted 
in the 1973 and 1976 criteria, is based upon common 
usage and has been retained by this subcommittee. 
Without a better understanding of the etiology or 
pathogenesis of this group of diseases, we saw little 
justification for changing a diagnostic term that had 
been used by physicians in the United States for the 
past 50 years. Indeed, the reasons for not altering 
nomenclature at this time were compelling in terms of 
the status of pediatric rheumatology as an emerging 
discipline. 
These clinical criteria for JRA define the age 
group of children under discussion, the objective cri- 
teria for a diagnosis of arthritis, the duration of disease 
during the entry period necessary for certainty of 
diagnosis (i.e., 6 weeks), the 3 types of onset, and the 
necessity of carefully considering diagnostic exclu- 
sions. 
The actual percentage of children first diag- 
nosed as having JRA who go on to develop another 
rheumatic disease during their disease course is not 
precisely known. The studies by Ansell and colleagues 
(8,9) have cast some light on this matter. Their classi- 
fication of juvenile polyarthritis indicates the percent- 
age (of children with an initial diagnosis of Still’s 
disease who developed another identifiable rheumatic 
syndrome during followup. Children originally consid- 
ered to have Still’s disease, as defined by the Taplow 
(England) group, but not fulfilling their criteria, were 
labeled in the initial studies as having probable Still’s 
disease. Followup by this same group of investigators 
has :shown that few of these children went on to 
develop a disease that met the classic criteria for Still’s 
disease. 
In a study by Dequeker and Mardjuadi (lo), 
further observations on the long-term course of chil- 
dren with juvenile chronic arthritis have been pro- 
vided. Only 3 of 96 patients characterized by a high 
frequency of B27 positivity (52%), a relatively late 
onset of disease, and male predominance were later 
reclassified as having developed clinical characteris- 
tics of spondylarthropathy. None, however, satisfied 
strict criteria for a diagnosis of ankylosing spondylitis 
in adults. In that study, HLA-B27 positivity did not 
appear to be a predictor of the subsequent develop- 
ment of typical ankylosing spondylitis or of eventual 
functional class. During the long followup period in 
that study, none of 11 children classified as having 
spondylarthropathy at disease onset progressed to 
having a definite diagnosis of ankylosing spondylitis 
(excluding 3 patients with Reiter’s syndrome and 1 
with psoriatic arthritis). All continued to have disease 
principally characterized by peripheral arthritis. 
A recent study by Jacobs et a1 (1 1) addressed 
the question of B27 positivity in a group of 58 children 
seen at Columbia University in New York City. The 
authors did not indicate in their review how many of 
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the clhildren were identified clinically, or could have 
been identified at onset, as having spondylarthropathy ; 
however, only 10 boys had radiologic sacroiliac arthri- 
tis at 5 years, and 3 had the Reiter triad. 
Although in the present study, children who 
were B27-positive, especially boys, tended to have 
lower extremity arthritis, all children in the Cincinnati 
database who had oligoarthritis had predominantly 
lower extremity arthritis, and few developed extensive 
disease of the upper extremities or cervical spine. 
Followup clinical and radiologic studies did not con- 
firm an interval development of features of spondyl- 
arthropathy. Whether these children will develop 
those features in the future is, of course, not evident 
now. This study does not confirm clinical impressions 
that indicate that B27 seropositivity is associated with 
the future development of spondylitis. 
Based on an analysis of rheumatoid factor 
seropositivity, it appeared that this variable selected a 
group of girls who tended to have a later age at onset 
of disease, with predominantly small joint involve- 
ment, and a poorer outcome than did members of 
comparable groups. However, it should be stressed 
that these observations have been made on the basis of 
screening by a slide test and confirmation by sensitized 
sheep cell agglutination, rather than a latex fixation 
test. Additionally, rheumatoid factor seropositivity did 
not always appear in  a child at the onset of the disease, 
and only in retrospect was it a group discriminator. 
Use of the SCAT failed to identify at disease onset at 
least one-third of the children who would eventually 
be seropositive. 
Rheumatoid factor-seropositive children with 
oligoa.rthritis tended to have much the same profile and 
outcome as rheumatoid factor-seropositive children 
with polyarthritis. In this specific analysis it appeared 
that rheumatoid factor seropositivity was an important 
prognostic factor, as compared with the number of 
joints involved at onset of disease. In contrast, how- 
ever, children with systemic disease who had poly- 
arthritis tended to develop clinical and radiologic 
features of their arthritis that were very similar to 
those in children with polyarthritis who were rheuma- 
toid factor-seropositive. In like manner, children with 
systernic disease who had oligoarthritis tended to 
develop disease similar to that in children with 
oligoarthritis who had not experienced a systemic 
onset. In these cases, the number ofjoints involved at 
onset or during the course of the disease, and not 
rheumatoid factor seropositivity, appeared to be the 
predominant factor determining outcome. 
Antinuclear antibody seropositivity was also 
examined as a discriminator of disease. In this study, 
ANA appeared to be associated with children who 
had polyarthritis or oligoarthritis and were female, 
younger at onset of disease, and had a lower percent- 
age of erosions. 
There were 17 children with oligoarthritis who 
developed chronic uveitis. In general, they had a very 
young age at disease onset versus children in other 
comparable groups, were predominantly girls, had a 
high frequency of ANA positivity, and a low fre- 
quency of erosions. The development of chronic 
uveitis in children in the Cincinnati database was 
delimited by the same parameters that had been iden- 
tified in numerous other studies (12). 
CONCLUSIONS 
1. Those children who were initially SCAT- 
positive or became SCAT-positive, whether the onset 
was polyarthritis or oligoarthritis, were older, included 
more females, had more ANA seropositivity, had 
more small joint involvement of the hands, more 
erosions, and were likely to experience a polyarthric 
course. SCAT positivity was unusual at any time in 
children with systemic onset. 
2. ANA seropositivity in children with poly- 
arthritis or oligoarthritis was associated with female 
sex and young age at disease onset. In children with 
oligoarthritis, chronic uveitis was strongly associated 
with ANA positivity. ANA positivity was not related 
to early development of erosions and was unusual at 
any time in children with systemic onset. 
3 .  HLA-B27 positivity was found in only 9% of 
the children in this study. This marker was associated 
with male sex and an older age at disease onset only in 
the children with oligoarthric onset. HLA-B27 was 
found chiefly in children who were SCAT-negative and 
ANA-negative. 
4. Excluding those children with SCAT and 
ANA positivity, children with polyarthritis were older 
than those with oligoarthritis, but there was no dis- 
cernible difference in sex distribution between these 2 
groups. 
5. In children with oligoarthritis, the knees were 
the joints most frequently involved, whatever the 
subsequent course. The fewer the involved joints 
during the subsequent course of the disease, the more 
the sex distribution was male-predominant. In this 
group, involvement of the wrists and proximal inter- 
phalangeal joints was absent in those with a monarth- 
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ric course, rare in those with an oligoarthric course, 
and fairly frequent in children with a polyarthric 
course. 
6 .  Children who developed chronic uveitis were 
almost exclusively female and younger by at least 3 
years than children in a comparable group without 
uveitis. The ratio of children with oligoarthritis who 
developed uveitis, compared with those who had 
polyarthritis, was 3: 1 .  
7. Children with systemic onset disease and 
either polyarthric or oligoarthric courses had the same 
articular characteristics as their counterparts with 
SCAT-positive or SCAT-negative oligoarthritis or 
polyarthritis. Children with systemic disease who ex- 
perienced a polyarthric course had a relatively 
younger age at disease onset and more hip disease than 
did comparable children with polyarthritis. Children 
with systemic onset disease who experienced an 
oligoarthric course were younger and were more likely 
to be male than were those children who had a 
polyarthric course. 
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